Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy

Eur Respir J. 2012 May;39(5):1263-6. doi: 10.1183/09031936.00129011.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Humans
  • Italy
  • Mycobacterium tuberculosis / drug effects*
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Pulmonary / drug therapy

Substances

  • Antitubercular Agents